Advancements in PET/CT Imaging and Theranostics in Nuclear Medicine

This cutting-edge course delivers a clinical perspective on the rapidly evolving landscape of PET/CT imaging and Theranostic agents in Nuclear Medicine. It covers the latest trends, economic, clinical, and academic aspects of PET/CT imaging and Nuclear Medicine therapy, providing a comprehensive understanding of the field.

Course Objectives

Upon completing this course, participants will be able to:

• Describe the latest developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy, with a focus on DOTA, PSMA, and PRRT.
• Discuss the logistics of bringing new diagnostic and therapeutic technologies to clinical practice.
• Identify key clinical indications for emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging.
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT.

With the recent approval of DOTATATE (NETSPOT) PET/CT by CMS Medicare and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, Nuclear Medicine and PET/CT are entering a new era. This course highlights the latest targeted imaging agents for neuroendocrine and prostate cancers, including Ga-68 DOTATATE and Ga-68 PSMA PET/CT, as well as reviews important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.

Target Audience

This course is designed for practicing radiologists, nuclear medicine physicians, radiologic nurses, physician assistants, technologists, residents, fellows, and others interested in the clinical applications of PET and PET/CT.

Course Curriculum

The comprehensive curriculum covers a range of topics, including:

• Introduction to Theranostics by Phillip Kuo
• Challenging and Instructive Abdomen and Pelvis PET/CT Review by Don Yoo
• Importance of Patient Preparation for PET/CT (Oncology and Cardiac Sarcoidosis) by Don Yoo
• PET/CT in Head and Neck Cancer by Don Yoo
• Update on Radioiodine Treatment for Thyroid Cancer and the Role of PET-CT by Don Yoo
• Nuclear Medicine and Benign Thyroid Disease by Andrew Quon
• Challenging and Interactive Chest PET/CT Review by Don Yoo
• Neuroendocrine Tumor Imaging with DOTA PET/CT by Andrew Quon
• Update on Nuclear Medicine for Infection and Inflammation by Don Yoo
• Lu-177 PSMA Therapy-Lessons from the Vision Trial by Phillip Kuo
• General Nuclear Medicine in 60 Minutes by Andrew Quon
• PET Imaging for the Differential Diagnosis of Dementia by Phillip Kuo
• Dopamine Transporter Imaging of Parkinsonian Syndromes by Phillip Kuo
• Somatostatin Radiotherapy: Our New Era of Nuclear Medicine Therapeutics by Andrew Quon
• Prostate Cancer PET Imaging by Andrew Quon
• Neurotheranostics: Next Frontier for Health Span by Phillip Kuo

This course is available as of December 14, 2023. Stay at the forefront of Nuclear Medicine and PET/CT advancements with this comprehensive course.